NCT04780659View on ClinicalTrials.gov

COVID-19 Vaccination of Immunodeficient Persons (COVAXID)

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

540

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

March 31, 2024

Study Completion Date

December 31, 2025

Conditions
Covid19
Interventions
BIOLOGICAL

Comirnaty (COVID-19, mRNA vaccine)

Comirnaty will be administered two times, one at Day 0 and the second dose at Day 21.

Trial Locations (1)

14186

Karolinska University Hospital, Stockholm

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

lead

Karolinska University Hospital

OTHER